Cargando…
Computation screening and molecular docking of FDA approved viral protease inhibitors as a potential drug against COVID-19
AIM: This study demonstrated potent inhibitors against COVID-19 using the molecular docking approach of FDA approved viral antiprotease drugs. BACKGROUND: COVID-19 has now spread throughout world. There is a serious need to find potential therapeutic agents. The 3C-like protease (Mpro/6LU7) is an at...
Autores principales: | Absalan, Abdorrahim, Doroud, Delaram, Salehi-Vaziri, Mostafa, Kaghazian, Hooman, Ahmadi, Nayebali, Zali, Fatemeh, Pouriavali's, Mohamamd Hassan, Mousavi-Nasab, Seyed Dawood |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682959/ https://www.ncbi.nlm.nih.gov/pubmed/33244378 |
Ejemplares similares
-
Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study
por: Mardani, Rajab, et al.
Publicado: (2020) -
Association of IL28B (IFNL3) rs12979860 mRNA levels, viral load, and liver function among HCV genotype 1a patients
por: Mousavi Nasab, Seyed Dawood, et al.
Publicado: (2019) -
Prevalence of astrovirus, adenovirus, and sapovirus infections among Iranian children with acute gastroenteritis
por: Mousavi Nasab, Seyed Dawood, et al.
Publicado: (2020) -
Association between serum inflammatory parameters and the disease severity in COVID‐19 patients
por: Mardani, Rajab, et al.
Publicado: (2021) -
A Real-Time RT-PCR Assay for Genotyping of Rotavirus
por: Mousavi-Nasab, Seyed Dawood, et al.
Publicado: (2020)